Frontiers in Endocrinology (Jun 2023)

Screening of lipids and kidney function in children and adolescents with Type 1 Diabetes: does age matter?

  • Eulalia Catamo,
  • Antonietta Robino,
  • Klemen Dovc,
  • Klemen Dovc,
  • Davide Tinti,
  • Gianluca Tamaro,
  • Riccardo Bonfanti,
  • Roberto Franceschi,
  • Ivana Rabbone,
  • Tadej Battelino,
  • Tadej Battelino,
  • Gianluca Tornese

DOI
https://doi.org/10.3389/fendo.2023.1186913
Journal volume & issue
Vol. 14

Abstract

Read online

IntroductionThe purpose of this study was to evaluate lipid profile and kidney function in children and adolescents with Type 1 Diabetes.MethodsThis was a retrospective study including 324 children and adolescents with Type 1 Diabetes (48% females, mean age 13.1 ± 3.2 years). For all participants, demographic and clinical information were collected. The prevalence of dyslipidemia and kidney function markers were analyzed according to age. Multivariate linear regression analyses were performed to test the association of lipids or markers of renal function with demographic and clinical information (sex, age, disease duration, BMI SDS, HbA1c).ResultsIn our study the rate of dyslipidemia reached 32% in children <11 years and 18.5% in those ≥11 years. Children <11 years presented significantly higher triglyceride values. While the albumin-to-creatinine ratio was normal in all individuals, 17% had mildly reduced estimated glomerular filtration rate. Median of HbA1c was the most important determinant of lipids and kidney function, being associated with Total Cholesterol (p-value<0.001); LDL Cholesterol (p-value=0.009), HDL Cholesterol (p-value=0.045) and eGFR (p-value=0.001).ConclusionDyslipidemia could be present both in children and adolescents, suggesting that screening for markers of diabetic complications should be performed regardless of age, pubertal stage, or disease duration, to optimize glycemia and medical nutrition therapy and/or to start a specific medical treatment.

Keywords